The expression of oncogenic KRASG12D at embryonic stages can induce pancreatic cancer in mice, which is accelerated by inactivation of Trp53, Cdkn2a or Smad4, genes that are frequently altered in human PDAC. This evidence concerns the gene CDKN2A and familial pancreatic carcinoma.